Arrowstreet Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.6M | Sell |
108,597
-679,380
| -86% | -$104M | 0.01% | 802 |
|
|
2025
Q4 | $109M | Buy |
+787,977
| New | +$103M | 0.06% | 282 |
|
|
2025
Q2 | – | Sell |
-916,894
| Closed | -$102M | – | 2031 |
|
|
2025
Q1 | $102M | Buy |
916,894
+905,842
| +8,196% | +$96.4M | 0.08% | 219 |
|
|
2024
Q4 | $1.08M | Sell |
11,052
-888,868
| -99% | -$94.8M | ﹤0.01% | 1425 |
|
|
2024
Q3 | $122M | Buy |
899,920
+269,209
| +43% | +$30.5M | 0.1% | 159 |
|
|
2024
Q2 | $67.1M | Buy |
630,711
+185,510
| +42% | +$18.6M | 0.06% | 254 |
|
|
2024
Q1 | $43.1M | Buy |
445,201
+389,298
| +696% | +$39.9M | 0.04% | 345 |
|
|
2023
Q4 | $5.64M | Buy |
55,903
+20,279
| +57% | +$1.96M | 0.01% | 716 |
|
|
2023
Q3 | $3.63M | Buy |
+35,624
| New | +$3.62M | ﹤0.01% | 727 |
|
|
2023
Q2 | – | Sell |
-176,652
| Closed | -$16.3M | – | 1399 |
|
|
2023
Q1 | $16.3M | Sell |
176,652
-3,950,430
| -96% | -$345M | 0.02% | 446 |
|
|
2022
Q4 | $374M | Buy |
4,127,082
+2,498,355
| +153% | +$210M | 0.52% | 52 |
|
|
2022
Q3 | $124M | Buy |
1,628,727
+59,534
| +4% | +$4.93M | 0.18% | 129 |
|
|
2022
Q2 | $133M | Sell |
1,569,193
-423,365
| -21% | -$37.1M | 0.19% | 125 |
|
|
2022
Q1 | $175M | Buy |
1,992,558
+1,010,806
| +103% | +$87.5M | 0.22% | 118 |
|
|
2021
Q4 | $85.9M | Buy |
981,752
+304,383
| +45% | +$25.3M | 0.11% | 208 |
|
|
2021
Q3 | $55.4M | Buy |
677,369
+340,669
| +101% | +$30.6M | 0.07% | 298 |
|
|
2021
Q2 | $30.7M | Buy |
336,700
+135,046
| +67% | +$12M | 0.04% | 458 |
|
|
2021
Q1 | $17.2M | Buy |
201,654
+196,839
| +4,088% | +$17.7M | 0.02% | 648 |
|
|
2020
Q4 | $455K | Sell |
4,815
-1,699,603
| -100% | -$149M | ﹤0.01% | 2035 |
|
|
2020
Q3 | $148M | Sell |
1,704,418
-1,363,892
| -44% | -$118M | 0.23% | 76 |
|
|
2020
Q2 | $268M | Sell |
3,068,310
-1,825,719
| -37% | -$158M | 0.49% | 30 |
|
|
2020
Q1 | $404M | Buy |
4,894,029
+835,693
| +21% | +$74.6M | 1.14% | 13 |
|
|
2019
Q4 | $384M | Buy |
4,058,336
+824,906
| +26% | +$74M | 0.89% | 14 |
|
|
2019
Q3 | $281M | Buy |
3,233,430
+210,489
| +7% | +$18.9M | 0.66% | 29 |
|
|
2019
Q2 | $276M | Sell |
3,022,941
-2,201,285
| -42% | -$186M | 0.62% | 40 |
|
|
2019
Q1 | $450M | Buy |
5,224,226
+1,579,113
| +43% | +$127M | 1.06% | 17 |
|
|
2018
Q4 | $280M | Buy |
3,645,113
+178,645
| +5% | +$13.9M | 0.73% | 31 |
|
|
2018
Q3 | $268M | Buy |
3,466,468
+2,696,763
| +350% | +$199M | 0.6% | 37 |
|
|
2018
Q2 | $52.1M | Buy |
769,705
+454,742
| +144% | +$31.4M | 0.13% | 170 |
|
|
2018
Q1 | $22.8M | Buy |
314,963
+137,073
| +77% | +$10.4M | 0.05% | 295 |
|
|
2017
Q4 | $13.4M | Buy |
177,890
+152,134
| +591% | +$11.5M | 0.03% | 388 |
|
|
2017
Q3 | $1.98M | Buy |
+25,756
| New | +$1.95M | 0.01% | 704 |
|
|
2017
Q2 | – | Sell |
-1,481,634
| Closed | -$98.6M | – | 1257 |
|
|
2017
Q1 | $98.6M | Buy |
+1,481,634
| New | +$98.7M | 0.36% | 67 |
|
|
2016
Q4 | – | Sell |
-79,348
| Closed | -$5.61M | – | 2272 |
|
|
2016
Q3 | $5.61M | Sell |
79,348
-58,238
| -42% | -$4.24M | 0.02% | 614 |
|
|
2016
Q2 | $10.2M | Buy |
+137,586
| New | +$9.51M | 0.03% | 418 |
|
|
2016
Q1 | – | Sell |
-543,111
| Closed | -$41.9M | – | 1462 |
|
|
2015
Q4 | $41.9M | Sell |
543,111
-945,209
| -64% | -$75.1M | 0.19% | 115 |
|
|
2015
Q3 | $123M | Buy |
1,488,320
+1,364,779
| +1,105% | +$121M | 0.58% | 36 |
|
|
2015
Q2 | $10.9M | Buy |
123,541
+40,845
| +49% | +$3.75M | 0.06% | 252 |
|
|
2015
Q1 | $7.31M | Sell |
82,696
-1,561,981
| -95% | -$139M | 0.05% | 339 |
|
|
2014
Q4 | $137M | Sell |
1,644,677
-1,283,978
| -44% | -$106M | 0.78% | 23 |
|
|
2014
Q3 | $247M | Buy |
2,928,655
+2,631,241
| +885% | +$213M | 1.33% | 10 |
|
|
2014
Q2 | $24.1M | Buy |
+297,414
| New | +$23.4M | 0.12% | 171 |
|
|
2014
Q1 | – | Sell |
-37,908
| Closed | -$2.73M | – | 1278 |
|
|
2013
Q4 | $2.73M | Sell |
37,908
-252,556
| -87% | -$17.6M | 0.01% | 584 |
|
|
2013
Q3 | $20M | Sell |
290,464
-765,653
| -72% | -$50.7M | 0.13% | 173 |
|
|
2013
Q2 | $66.9M | Buy |
+1,056,117
| New | +$68.7M | 0.5% | 55 |
|
Other funds holding NVS
Arrowstreet Capital's NVS Position: Q1 2026 in Review
Arrowstreet Capital reduced its Novartis (NVS) stake by 86% in Q1 2026, selling an estimated $104M and leaving 108,597 shares worth $16.6M. The position accounts for 0.01% of the portfolio, ranked #802.
Arrowstreet Capital first reported a position in NVS in Q2 2013 and has held it in 45 quarters since. The position peaked at $450M in Q1 2019. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Arrowstreet Capital held 108,597 shares of Novartis worth $16.6M as of Q1 2026.
- Arrowstreet Capital sold 679,380 Novartis shares in Q1 2026, an estimated $104M.
- Novartis made up 0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #802 holding.
- Arrowstreet Capital first reported a position in Novartis in Q2 2013 and has held it in 45 quarters since.
- Arrowstreet Capital's Novartis position peaked at $450M in Q1 2019.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.